Department of Pediatrics Archive — Page 32 of 56
-
June 4, 2020
Remdesivir helps reduce COVID-19 recovery time: study
The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine. -
June 3, 2020
Children’s Hospital experts say well-child visits remain as crucial as ever
Pediatricians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are stressing the continued importance of well-child visit for infants, children and adolescents, particularly during the COVID-19 pandemic. -
June 3, 2020
Study explores how staph bacteria can survive in bone
A comprehensive evaluation of the metabolic pathways that support Staphylococcus aureus (“staph”) growth during invasive bone infections could offer new targets for treatment. -
May 27, 2020
Experts offer tips for managing and monitoring adolescent mental health
As families are managing the restrictions that the COVID-19 pandemic presents, doctors at Monroe Carell Jr. Children’s Hospital at Vanderbilt are urging parents to pay close attention to the behaviors of their children. -
May 27, 2020
Research probes why COVID-19 seems to spare young children
Lung disease experts at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. -
May 21, 2020
State cancer plan has robust input and commitment from Vanderbilt-Ingram Cancer Center
More than a dozen representatives of Vanderbilt University Medical Center helped plan and made a commitment to help carry out the strategy for how Tennessee will prevent cancer and minimize its burden on state residents. -
May 18, 2020
Women in criminal justice system less likely to receive evidence-based treatment for opioid use disorder
Pregnant women involved in the criminal justice system are disproportionately not receiving medications for opioid use disorder, as compared to their peers, according to a Vanderbilt-led study published today in PLOS Medicine.